Brand semaglutide
Sold by NovoCare Pharmacy · Injection, pen · every brand semaglutide record
What you actually pay
Per month
$50
| Medication · Medicare price, Medicare GLP-1 Bridge program | $50 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Cash/self-pay price via NovoCare Pharmacy, new patients, lowest starting doses (0.25mg & 0.5mg), first 2 fills “Patients new to the Wegovy ® Savings Offer or NovoCare ® Pharmacy pay $199 for each month of 0.25 mg & 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy ® 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg, and $399 per month for Wegovy ® HD (semaglutide) injection 7.2 mg.” | Per month$199 | Charged today$199 |
| Commercial insurance copay, with savings offer “Your copay could be as little as $25/month d ( with a maximum savings of $100/month) if you have commercial (non-government) insurance.” | Per month$25 | Charged today$25 |
| Medicare price, Medicare GLP-1 Bridge program “Starting July 1, eligible Medicare patients pay $50 per month g for Wegovy ® , through the Medicare GLP-1 Bridge program. This pricing is for adult patients with Medicare prescribed Wegovy ® for weight loss only.” | Per month$50 | Charged today$50 |
We earn nothing from this link. NovoCare Pharmacy has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
Not yet checked: pharmacy, states, prescriber, cancellation, membership and consult fee.
Notes
- 1. September 2, 2026 — This is Novo Nordisk's own manufacturer site (novocare.com), not an independent telehealth provider — 'NovoCare Pharmacy' is Novo Nordisk's own direct-fulfillment pharmacy program for its brand Wegovy, and this page assumes the patient already has a prescription from their own doctor ('take it to your pharmacy with your prescription'); there is no telehealth consult or prescribing service offered on this page, so prescriber is not-found rather than guessed. Three separate published prices exist for the same drug depending on payer: a commercial-insurance copay as low as $25/month (capped at $100/month in savings), a Medicare price of $50/month via the 'Medicare GLP-1 Bridge program,' and self-pay/cash prices through NovoCare Pharmacy that vary by dose and form ($199/mo rising to $349-$399/mo for the injection pen after an introductory period; $149-$299/mo by dose for the tablet). All are recorded as separate entries per the brief's insurance-vs-cash rule. No cancellation/return policy or served-state list appears on this page; full terms are referenced at external domains (WegovyTerms.com, NovoCarePharmacyTerms.com) that were not part of this fetch.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.